LINC01326

Across TCGA pan-cancer cohorts, LINC01326 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated LINC01326 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC01326 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01326 expression acts as an unfavorable survival marker, although some lineages such as LUSC and ESCA show a favorable association.

HNSC, THYM, and LUSC are the cancer types where LINC01326 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.675	0.770	.003	86	view →
THYM	DFS	Tertile	All	0.567	0.892	<.001	81	view →
LUSC	DFS	Tertile	II,III,IV	0.736	0.560	.006	56	view →
THCA	DFS	Tertile	All	0.049	0.828	<.001	54	view →
LAML	DFS	Tertile	All	0.165	0.581	.034	36	view →
KIRC	DFS	Tertile	All	0.337	0.654	.012	12	view →
GBM	OS	Tertile	All	0.239	0.449	.017	9	view →
ESCA	OS	Quartile	II,III,IV	0.874	0.661	.026	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

LINC01326–HNSC (OS)

Open the HNSC breakdown →